Tianyi Jiang - 18 Sep 2025 Form 4 Insider Report for AvePoint, Inc. (AVPT)

Role: Chief Executive Officer, Director
Signature: /s/ Brian Michael Brown, Attorney-in-Fact
Issuer symbol: AVPT
Transactions as of: 18 Sep 2025
Net transactions value: -$31,468,973
Form type: 4
Filing time: 22 Sep 2025, 19:02:03 UTC
Previous filing: 16 Sep 2025
Next filing: 23 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Jiang Tianyi	Chief Executive Officer, Director	C/O AVEPOINT, INC., 525 WASHINGTON BOULEVARD, SUITE 1400, JERSEY CITY	/s/ Brian Michael Brown, Attorney-in-Fact	22 Sep 2025	0001865596

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AVPT	Common Stock	Sale	$31,468,973	-2,068,966	-13%	$15.21	13,841,853	18 Sep 2025	Held by trusts and LLCs	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported sale of shares was made pursuant to the Company's secondary listing on the Singapore Exchange Securities Trading Limited ("SGX-ST") on September 18, 2025. The sale was executed to facilitate initial liquidity in connection with the SGX-ST listing. The reporting person undertook the transaction in accordance with Rule 144 and applicable insider trading policies. No shares were sold on NASDAQ in connection with this transaction.
F2	Includes (i) 2,668,057 shares held by Dr. Jiang's affiliate River Valley Ltd., (ii) 2,678,631 shares held by Red Kite LLC, each of which Dr. Jiang may be deemed to beneficially own, (iii) 837,060 shares held by Capella 2022 GRAT II, (iv) 3,338,392 shares held by the Capella 2023 GRAT, (v) 2,888,135 shares held by Capella 2024 GRAT, (vi) 1,259,578 shares held by Capella 2024 GRAT II, in case of each of (iii)-(vi), for which Dr. Jiang is the trustee and (vii) 172,000 shares held by Dr. Jiang's spouse. The Reporting Person disclaims beneficial ownership with respect to the shares held by each trust and LLC, except to the extent his pecuniary interest therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose.

Content

The reported sale of shares was made pursuant to the Company's secondary listing on the Singapore Exchange Securities Trading Limited ("SGX-ST") on September 18, 2025. The sale was executed to facilitate initial liquidity in connection with the SGX-ST listing. The reporting person undertook the transaction in accordance with Rule 144 and applicable insider trading policies. No shares were sold on NASDAQ in connection with this transaction.

Includes (i) 2,668,057 shares held by Dr. Jiang's affiliate River Valley Ltd., (ii) 2,678,631 shares held by Red Kite LLC, each of which Dr. Jiang may be deemed to beneficially own, (iii) 837,060 shares held by Capella 2022 GRAT II, (iv) 3,338,392 shares held by the Capella 2023 GRAT, (v) 2,888,135 shares held by Capella 2024 GRAT, (vi) 1,259,578 shares held by Capella 2024 GRAT II, in case of each of (iii)-(vi), for which Dr. Jiang is the trustee and (vii) 172,000 shares held by Dr. Jiang's spouse. The Reporting Person disclaims beneficial ownership with respect to the shares held by each trust and LLC, except to the extent his pecuniary interest therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose.